Literature DB >> 8845949

IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage.

E Fattori1, D Lazzaro, P Musiani, A Modesti, T Alonzi, G Ciliberto.   

Abstract

Growing evidence suggests that aberrant production of inflammatory cytokines within the central nervous system (CNS) contributes to the development of pathological conditions. To test the cause-effect relationship between the overproduction of interleukin-6 (IL-6) in the CNS and the onset of neuropathological changes, we have generated transgenic mice in which human IL-6 expression has been targeted to the neurons by using the rat neuron-specific enolase promoter. These mice develop reactive astrocytosis and an increase in ramified microglial cells but do not show histological or behavioural signs of neuron damage at the light microscope level. We thus conclude that a constant release of human IL-6 by neuronal subpopulations in mice is sufficient to activate cells potentially capable of modulating the local immune response, but at the same time is compatible with normal neuron functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845949     DOI: 10.1111/j.1460-9568.1995.tb01042.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  38 in total

1.  IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.

Authors:  Tomoya Nakamachi; Masashi Tsuchida; Nobuyuki Kagami; Sachiko Yofu; Yoshihiro Wada; Motohide Hori; Daisuke Tsuchikawa; Akira Yoshikawa; Nori Imai; Keisuke Nakamura; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-06       Impact factor: 3.444

2.  The Brain's Aging Immune System.

Authors:  Wolfgang J Streit; Qing-Shan Xue
Journal:  Aging Dis       Date:  2010-12-01       Impact factor: 6.745

3.  Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide.

Authors:  Y Huang; C J Henry; R Dantzer; R W Johnson; J P Godbout
Journal:  Neurobiol Aging       Date:  2007-05-31       Impact factor: 4.673

Review 4.  Immune players in the CNS: the astrocyte.

Authors:  Cathy J Jensen; Ann Massie; Jacques De Keyser
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

5.  IL-6 transgenic mouse model for extraosseous plasmacytoma.

Authors:  Alexander L Kovalchuk; Joong Su Kim; Sung Sup Park; Allen E Coleman; Jerrold M Ward; Herbert C Morse; Tadamitsu Kishimoto; Michael Potter; Siegfried Janz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

6.  Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.

Authors:  F De Benedetti; T Alonzi; A Moretta; D Lazzaro; P Costa; V Poli; A Martini; G Ciliberto; E Fattori
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 7.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

8.  A novel role for protein tyrosine phosphatase shp1 in controlling glial activation in the normal and injured nervous system.

Authors:  A Horvat; F Schwaiger; G Hager; F Brocker; R Streif; P Knyazev; A Ullrich; G W Kreutzberg
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

9.  Induction of interleukin-6 by depolarization of neurons.

Authors:  S Sallmann; E Jüttler; S Prinz; N Petersen; U Knopf; T Weiser; M Schwaninger
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

10.  TLR3 ligand Poly IC Attenuates Reactive Astrogliosis and Improves Recovery of Rats after Focal Cerebral Ischemia.

Authors:  Yang Li; Xu-Lin Xu; Dan Zhao; Lin-Na Pan; Chun-Wei Huang; Lian-Jun Guo; Qing Lu; Jian Wang
Journal:  CNS Neurosci Ther       Date:  2015-11       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.